FDG PET/Vascular contrast CT for oncological studies in small animals: A method for assessing hypoxia?

被引：0
|
作者：
Nanni, C. [1 ]
Galie, M. [2 ]
Spinelli, A. [3 ]
Farace, P. [2 ]
Trespidi, S. [4 ]
Marzola, P. [2 ]
Ambrosini, V. [1 ]
Lodi, F. [4 ]
Pettinato, C. [3 ]
Quarta, C. [1 ]
Franchi, R. [1 ]
Fanti, S. [1 ]
机构：
[1] S Orsola Nucl Med, Bologna, Italy
[2] Anat Univ Verona, Verona, Italy
[3] S Orsola Med Phys, Bologna, Italy
[4] S Orsola Radiopharm, Bologna, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S231 / S232
页数：2
相关论文
共 50 条
  • [21] The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients
    Cerci, Juliano Julio
    Pereira Neto, Carlos Cunha
    Krauzer, Cassiano
    Sakamoto, Danielle Giacometti
    Vitola, Joao Vicente
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (01) : 98 - 103
  • [22] Oncological therapy monitoring by whole body FDG-PET/CT using a semi-automated method
    Sundin, A.
    Nair, M.
    Van Nuffel, A.
    Kohlmyer, S.
    Razifar, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S350 - S350
  • [23] Utility of inclusion of lower limbs in oncological FDG PET/CT imaging.
    Cohade, C
    Mourtzikos, KA
    Wahl, RL
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 376P - 377P
  • [24] Management of hyperglycemia in oncological patients scheduled for an FDG-PET/CT examination
    Laura Evangelista
    Stefania Gori
    Giuseppe Rubini
    Marco Gallo
    Clinical and Translational Imaging, 2019, 7 : 447 - 450
  • [25] FDG uptake in synthetic aortic vascular graft on FDG-PET/CT
    Ishibashi, M.
    Ishimori, T.
    Nakashita, S.
    Ikeda, I.
    Yabuta, M.
    Sakata, A.
    Kawamura, A.
    Yamada, T.
    Nobashi, T.
    Nishimatsu, K.
    Watanabe, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S377 - S377
  • [26] The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients
    Juliano Julio Cerci
    Carlos Cunha Pereira Neto
    Cassiano Krauzer
    Danielle Giacometti Sakamoto
    João Vicente Vitola
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 98 - 103
  • [27] Management of hyperglycemia in oncological patients scheduled for an FDG-PET/CT examination
    Evangelista, Laura
    Gori, Stefania
    Rubini, Giuseppe
    Gallo, Marco
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (06) : 447 - 450
  • [28] Role of FDG PET/CT in tumours of the small intestine
    Montravers, F.
    Loi, V.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2014, 38 (05): : 369 - 374
  • [29] Performance of integrated FDG–PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG–PET/non-contrast-enhanced CT and enhanced CT
    Kazuhiro Kitajima
    Koji Murakami
    Erena Yamasaki
    Yasushi Domeki
    Yasushi Kaji
    Ichio Fukasawa
    Noriyuki Inaba
    Narufumi Suganuma
    Kazuro Sugimura
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35
  • [30] Performance of integrated FDG PET/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: Comparison with integrated FDG PET/non-contrast-enhanced CT and enhanced CT
    Kitajima, Kazuhiro
    Murakami, Koji
    Yamasaki, Erena
    Domeki, Yasushi
    Tsubaki, Masahiro
    Sunagawa, Masakatsu
    Kaji, Yasushi
    Suganuma, Narufumi
    Sugimura, Kazuro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (09) : 1388 - 1396
12345